DexCom Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.
DexCom Inc. (DXCM) shares fell 4.20% to $58.57 on Wednesday, underperforming against competitors like Abbott Laboratories and Insulet Corp. The S&P 500 rose 0.58%, while the Dow Jones dipped 0.14%. DexCom's stock is currently 34.91% below its 52-week high of $89.98 reached on July 30. Trading volume was 7.0 million, surpassing the 50-day average of 4.5 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments